aid: celecor-therapeutics

name: CeleCor Therapeutics

description: 'CeleCor Therapeutics is a clinical-stage biopharmaceutical company focused on developing innovative therapies for patients experiencing ST-segment elevation myocardial infarctions (STEMI). Their flagship program, Disaggpro™, aims to deliver a rapid, pre-hospital treatment to reduce mortality and improve outcomes for heart attack patients. The company provides background resources, clinical trial information, and an expanded access policy through its website.'

url: https://raw.githubusercontent.com/api-evangelist/celecor-therapeutics/refs/heads/main/apis.yml

x-type: company

x-source: harvest:secondary-market

x-tier: profiled
x-tier-reason: enrichment pass 2026-10-07 (modular-v1; was harvest)

specificationVersion: '0.20'

created: '2026-10-07'

modified: '2026-10-07'

x-coverage:
  state: unreadable
  reason: no-machine-readable-spec
  detail: The provider's website offers only static HTML documentation with no machine‑readable API specification.
  evidence:
    - url: https://www.celecor.com/
      status: 200
  checked: '2026-10-07'

tags:
- Biopharma
- Cardiovascular
- ClinicalTrials
- STEMI
- Therapeutics

maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io

common:
- type: Hosts
  url: hosts/celecor-therapeutics-hosts.yml
- type: DomainSecurity
  url: security/celecor-therapeutics-domain-security.yml
- type: Website
  url: https://www.celecor.com/
- type: Documentation
  url: https://www.celecor.com/about/
- type: Blog
  url: https://www.celecor.com/news/

apis: []
x-enrichment:
  date: '2026-10-07'
  status: enriched
  artifacts_added: 5
  pass: modular-v1
  engine: identity=local,contract=local,surfaces=local,docs=local,regulatory=local